Press Release from Annual Shareholders’ Meeting in Pandox Aktiebolag (publ) on 3 May 2016

Regulatory News:

At the annual shareholders’ meeting in Pandox Aktiebolag (publ) (STO:PNDXB) in Stockholm today the shareholders resolved upon the following:

Approval of income statement and balance sheet for the financial year 2015 and discharge from liability

The annual shareholders’ meeting approved the income statement and balance sheet as well as the consolidated income statement and the consolidated balance sheet for the financial year 2015, and the members of the board and the managing director were discharged from liability for the financial year 2015.

Allocation of profit or loss

The shareholders’ meeting resolved, in accordance with the board’s proposal, that the funds at the meeting’s disposal should be allocated so that SEK 2,455,870,711 is allocated as dividends to the shareholders of SEK 3.80 per share, in total SEK 570,000,000, and that the remaining unrestricted equity, SEK 1,885,870,711, is carried forward. Friday 6 May 2016 was resolved as record day for dividends.

Election of board members, auditors, fees to the board of directors and auditors

The annual shareholders’ meeting resolved, in accordance with the nomination committee’s proposal, that the number of members of the board of directors shall be seven without deputy members, and that the company shall have two auditors and two deputy auditors.

In accordance with the nomination committee’s proposal, Christian Ringnes, Leiv Askvig, Ann-Sofi Danielsson, Olaf Gauslå, Bengt Kjell, Helene Sundt and Mats Wäppling were re-elected as board members for the time until the end of the next annual shareholders’ meeting. Christian Ringnes was re-elected as chairman of the board. Per Gustafsson and Willard Möller were re-elected as auditors, Ulf Sundborg was re-elected as deputy auditor and Bengt Ekenberg was elected as new deputy auditor.

The annual shareholders’ meeting further resolved, in accordance with the nomination committee’s proposal, that the fees to board shall be SEK 3,370,000 in total, allocated as follows: SEK 600,000 shall be paid to the chairman of the board and a fee of SEK 400,000 shall be paid to each of the other board members. Fees for committee work shall be paid with SEK 50,000 to each of the two members of the remuneration committee (including the chairman), SEK 130,000 to the chairman of the audit committee and SEK 70,000 to each of the other two members of the audit committee. The annual shareholders’ meeting further resolved that, in accordance with the nomination committee’s proposal, auditor fees shall be paid in accordance with approved invoice.

Guidelines for remuneration for members of management

The annual shareholders’ meeting resolved to adopt guidelines for remuneration of members of management in accordance with the board’s proposal. In short, the guidelines state that the total remuneration to members of management of Pandox should be competitive in comparison to that of similar companies in order to attract, motivate and retain key employees. Remuneration to members of management shall consist of base salary, short-term incentive programs as well as long-term share price based incentive programs, in addition to pension and other customary benefits.

Nomination committee for the annual shareholders’ meeting 2017

The annual shareholders’ meeting resolved to, in accordance with the nomination committee’s proposal, adopt principles for the appointment of the nomination committee for the annual shareholders’ meeting 2017. In short, the nomination committee shall be composed of representatives of the four largest shareholders as of 31 July 2016 together with the chairman of the board.

Authorisation to issue new shares

The annual shareholders’ meeting resolved to, in accordance with the board’s proposal, authorise the board to resolve - at one or several occasions and for the time period until the next annual shareholders’ meeting - to increase the company’s share capital by new share issues, to the extent that it corresponds to a dilution of not more than 10 percent of the number of shares outstanding at the time of the notice of the annual shareholders’ meeting. New share issues may be made with or without deviation from the shareholders’ preferential rights and with or without provisions for contribution in kind, set-off or other conditions.

Additional information from the annual shareholders’ meeting

The presentation made by CEO Anders Nissen at the annual shareholders’ meeting is also available on Pandox website, www.pandox.se. Minutes from the annual shareholders’ meeting will be made available on Pandox website no later than two weeks after the annual shareholders’ meeting.

This information was submitted for publication on 3 May 2016 at 17:oo CEST.

About Pandox

Pandox is a leading owner of hotel properties in Northern Europe with a focus on sizeable hotels in key leisure and corporate destinations. Pandox’s hotel property portfolio comprises 113 hotels with more than 24,000 hotel rooms in eight countries. Pandox’s business is organised into Property management, which comprises hotel properties leased on a long-term basis to market leading regional hotel operators and leading international hotel operators, and Operator activities, which comprises hotel operations executed by Pandox in its owner-occupied hotel properties. Pandox was founded in 1995 and the company’s B shares are, as of 18 June 2015, listed on Nasdaq Stockholm. www.pandox.se

This information was brought to you by Cision http://news.cision.com

View source version on businesswire.com: http://www.businesswire.com/news/home/20160503006471/en/